7449 related articles for article (PubMed ID: 2672685)
1. Hyperpigmentary disorders--mechanisms of action. Effect of azelaic acid on melanoma and other tumoral cells in culture.
Breathnach AS; Robins EJ; Nazzaro-Porro M; Passi S; Picardo M
Acta Derm Venereol Suppl (Stockh); 1989; 143():62-6. PubMed ID: 2672685
[TBL] [Abstract][Full Text] [Related]
2. Effect of dicarboxylic (C6 and C9) acids on a human squamous carcinoma cell line in culture.
Pätzold HC; Breathnach AS; Robins EJ; Daridan ME; Bhasin YP; Ethridge LB; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1989 Apr; 4(2):167-71. PubMed ID: 2520453
[TBL] [Abstract][Full Text] [Related]
3. Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture.
Breathnach AS; Robins EJ; Pätzold HC; Bhasin YP; Ethridge LB; Garner A; Nazzaro-Porro M
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):491-8. PubMed ID: 2925320
[TBL] [Abstract][Full Text] [Related]
4. Azelaic acid: mode of action at cellular and subcellular levels.
Galhaup I
Acta Derm Venereol Suppl (Stockh); 1989; 143():75-82. PubMed ID: 2475996
[TBL] [Abstract][Full Text] [Related]
5. Azelaic acid: potential as a general antitumoural agent.
Breathnach AS
Med Hypotheses; 1999 Mar; 52(3):221-6. PubMed ID: 10362281
[TBL] [Abstract][Full Text] [Related]
6. Observations on cell kinetics and viability of a human melanoma cell line exposed to dicarboxylic acids in tissue culture.
Breathnach AS; Robins EJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1986 Jul; 1(3):235-9. PubMed ID: 2980117
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic activity of azelaic acid against human melanoma primary cultures and established cell lines.
Zaffaroni N; Villa R; Silvestro L; Sanfilippo O; Silvestrini R
Anticancer Res; 1990; 10(6):1599-602. PubMed ID: 2285231
[TBL] [Abstract][Full Text] [Related]
8. [Effect of azelaic acid on the growth of melanoma cell cultures in comparison with fibroblast cultures].
Geier G; Hauschild T; Bauer R; Kreysel HW
Hautarzt; 1986 Mar; 37(3):146-8. PubMed ID: 3700102
[TBL] [Abstract][Full Text] [Related]
9. Scanning electron microscopy of human and murine melanoma cells exposed to medium chain-length (C6-C12) dicarboxylic acids in tissue culture.
Breathnach AS; Robins EJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Histol Histopathol; 1987 Jul; 2(3):291-7. PubMed ID: 2980732
[TBL] [Abstract][Full Text] [Related]
10. The depigmenting effect of azelaic acid.
Nazzaro-Porro M; Passi S; Zina G; Breathnach AS
Arch Dermatol; 1990 Dec; 126(12):1649-51. PubMed ID: 2073286
[No Abstract] [Full Text] [Related]
11. Effect of azelaic acid on melanoma cells in culture.
Lemic-Stojcevic L; Nias AH; Breathnach AS
Exp Dermatol; 1995 Apr; 4(2):79-81. PubMed ID: 7640879
[TBL] [Abstract][Full Text] [Related]
12. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders.
Fitton A; Goa KL
Drugs; 1991 May; 41(5):780-98. PubMed ID: 1712709
[TBL] [Abstract][Full Text] [Related]
13. Activity of azelaic acid on cultures of lymphoma- and leukemia-derived cell lines, normal resting and stimulated lymphocytes and 3T3 fibroblasts.
Picardo M; Passi S; Sirianni MC; Fiorilli M; Russo GD; Cortesi E; Barile G; Breathnach AS; Nazzaro-Porro M
Biochem Pharmacol; 1985 May; 34(10):1653-8. PubMed ID: 4004885
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
[TBL] [Abstract][Full Text] [Related]
15. Effect of L-carnitine on cultured murine melanoma cells exposed to azelaic acid.
Ward BJ; Breathnach AS; Robins EJ; Bhasin YP; Ethridge L; Nazzaro-Porro M; Passi S
J Invest Dermatol; 1986 Apr; 86(4):438-41. PubMed ID: 3745962
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
17. [Dicarboxylic acids inhibit the growth of keratinocytes in vitro].
Detmar M; Müller R; Stadler R; Orfanos CE
Hautarzt; 1986 Nov; 37(11):625-7. PubMed ID: 3804734
[TBL] [Abstract][Full Text] [Related]
18. Topographical analysis of proliferation ([3H]thymidine labelling index and mitotic index) as compared with tumour growth and tumour weight in xenotransplanted melanoma. Changes due to local and systemic application of azelaic acid.
Nüssgen AI; Fritz U; Graupe K; Breitbart EW; Schmiegelow P
Acta Derm Venereol Suppl (Stockh); 1989; 143():67-74. PubMed ID: 2773615
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and a human melanoma cell line in tissue culture.
Robins EJ; Breathnach AS; Bennett D; Ward BJ; Bhasin Y; Ethridge L; Nazzaro-Porro M; Passi S; Picardo M
Br J Dermatol; 1985 Dec; 113(6):687-97. PubMed ID: 4096883
[TBL] [Abstract][Full Text] [Related]
20. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro.
Kirshenbaum MR; Chen SF; Behrens CH; Papp LM; Stafford MM; Sun JH; Behrens DL; Fredericks JR; Polkus ST; Sipple P
Cancer Res; 1994 Apr; 54(8):2199-206. PubMed ID: 8174127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
